Trial Information

Summary: Expanded Access Program (EAP) of Maraviroc

NYU School of Medicine is conducting a research study to help give people another treatment option where there are limited or no other options available because of resistance or intolerance of all currently approved HIV medications.

You may be eligible to participate in this study if you:

• Are at least 18 years of age
• You are HIV positive and treatment-experienced
• You require maraviroc as a treatment due to limited or nonexistent treatment options as determined by your doctor
• You have an HIV-1 RNA of 1000 or more copies/mL
• If you are a woman able to have children, your urine pregnancy test must be negative prior to the first dose of study medication

Other entry requirements must be met. All eligible subjects will receive maraviroc at no cost. Maraviroc will be taken with the best combination of currently approved medications for you as determined by your doctor. You will need to pay for these additional medications.

If you would like to learn more about participating in this study, please send an e-mail message using the form below.